Application 203323

Type
ANDA
Sponsor
SAGENT PHARMS INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001AMIKACIN SULFATEAMIKACIN SULFATEINJECTABLE;INJECTIONEQ 250MG BASE/MLNoNo
002AMIKACIN SULFATEAMIKACIN SULFATEINJECTABLE;INJECTION500MG(BASE)/ML(250MG/ML)YesNo
003AMIKACIN SULFATEAMIKACIN SULFATEINJECTABLE;INJECTION1G(BASE)/4ML(250MG/ML)YesNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
25021-173amikacin sulfateamikacin sulfateSagent PharmaceuticalsANDACurrent
25021-173amikacin sulfateamikacin sulfateSagent PharmaceuticalsANDACurrent
25021-173amikacin sulfateamikacin sulfateSagent PharmaceuticalsANDACurrent